Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARBITAR Trial: ARB in Patients After TAVR for Severe AS With LVH
NCT07735130Phase 4Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2026
- Primary completion
- Jun 2030
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in aortic stenosis (AS) and left ventricular hypertrophy (LVH) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Composite of all-cause death or admission for heart failure at 2 years. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
aortic stenosis (AS)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT07735130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07735130.